SCHEMBL3032027

SCHEMBL3032027

CC(NC(=O)c1ccc2cc(C(=O)NO)ccc2c1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.55
GPR139 Q6DWJ6 1/20 0.52
HDAC6 Q9UBN7 1/20 0.51
PPARG P37231 2/20 0.50
PIN1 Q13526 1/20 0.48
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.47
LIPG Q9Y5X9 1/20 0.46
DDR2 Q16832 2/20 0.46
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ROCK2 O75116 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2409579 0.86 NPSR1 (0.56) NPSR1GPR139LMNASMN1; SMN2TAS1R3
SCHEMBL13890815 0.82 GPR139 (0.65) NPSR1GPR139PPARGMEN1LMNA
SCHEMBL3036088 0.82 ALDH1A1 (0.64) MEN1LMNAPOLBHTTKMT2A
SCHEMBL3023784 0.81 ROCK1 (0.64) ROCK2ROCK1
SCHEMBL3032715 0.81 ROCK1 (0.64) ROCK2ROCK1
SCHEMBL31072845 0.80 PPARG (0.52) NPSR1GPR139PPARGTAS1R3TAS1R1
SCHEMBL29342693 0.80 PPARG (0.52) NPSR1GPR139PPARGTAS1R3TAS1R1
SCHEMBL2411650 0.80 GPR139 (0.59) NPSR1GPR139HDAC6MEN1LMNA
SCHEMBL27931832 0.79 ROCK1 (0.56) NPSR1GPR139KMT2AALDH1A1L3MBTL1
SCHEMBL22915847 0.79 DDR2 (0.52) NPSR1GPR139PPARGMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 NPSR1 3399/4885GPR139 2941/4885HDAC6 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.